HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Shifts Innovation Focus From Growing Sales In Core Segments To Expanding Categories

Executive Summary

Colgate shifts innovation focus to product launches that expand categories and grow sales for the long term. “We have to expand the pie in the categories that we compete … we’re not going to do that with simply core adjacencies,” says CEO Noel Wallace.

You may also be interested in...



Colgate Stays Course On Earnings Forecast Against Stormy Headwinds From Costs

Higher material and packaging costs in North America drove Colgate’s Q2 operating profit down 21%. Oral care sales were the bright spot in an otherwise difficult quarter in North America, where total sales declined 4% due to COVID-related demand in 2020 and competitive pressure.

Colgate Investment In E-Commerce Staff, Online Brands Pays Off: Sales Up 50%

Strategies including enhanced capabilities, more external talent and online-only launches boosted e-commerce business with 50% sales growth in the fourth quarter. Net sales are anticipated to grow 4% to 7% in 2021.

At Colgate Helm, Wallace Expected To Continue Cook's Strategies

Noel Wallace, also named to board, says Colgate will continue to prioritize brand building, innovation in current product segments, expanding in channels and markets, maximizing e-commerce growth and investing to drive penetration in growing populations. He joined the oral, personal and home care product and pet nutrition company in 1987 and has served in senior management roles around the world.

Topics

Related Companies

UsernamePublicRestriction

Register

RS151741

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel